Search
Oramed Pharmaceuticals Inc
ORMPAdd to Watchlist
4.300USD
0.0000.00%
Close 08-07 16:00（ET）Quotes delayed by 15 min
175.98MMarket Cap
1.61P/E TTM
Forecast
Currency: USD Updated: 2026-08-07No earnings forecast score is currently available for Oramed Pharmaceuticals Inc. The Biotechnology & Medical Research industry's average is 8.10. The average price target is 3.25, with a high of 3.25 and a low of 3.25.
Analyst Rating
Based on
0
analysts
--
Current Rating
6.250
Target Price
+45.35%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
Oramed Pharmaceuticals Inc
ORMP
0
Beigene Ltd
ONC
28
argenx SE
ARGX
28
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Oramed Pharmaceuticals Inc's price target?
Analysts forecast that Oramed Pharmaceuticals Inc's price target is USD 3.25, with the highest forecast at USD 3.25 and the lowest forecast at USD 3.25.